1. Home
  2. News
  3. Mayne Pharma Group Ltd.
  4. Court approves convening of scheme meeting
More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

Court approves convening of scheme meeting

May 15, 2025 at 1:13 AM EDT · Issued by Mayne Pharma Group Ltd.

Filed with ASX · May 15, 2025 at 1:13 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/court-approves-convening-of-scheme-meeting-7

Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26↗

Mayne Pharma Group Ltd. on 6ix

Story so far

  • Issuance of additional US Patent for NEXTSTELLISNov 6, 2023
  • MYX signs license agreement for womens health productsDec 5, 2022
  • Mayne Pharma and Mithra announce FDA approval of Haloette, a generic version of NuvaringAug 8, 2022

Earlier from Mayne Pharma

  • Response to ASX Price QueryMay 14, 2025
  • Pause in TradeMay 14, 2025
  • Response to ASX QueryMay 11, 2025
  • Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.Apr 17, 2025
  • 2025 Half Year Investor PresentationFeb 25, 2025

Later from Mayne Pharma

  • ASIC registration of Mayne Pharma scheme bookletMay 15, 2025
  • Update on Scheme with CosetteMay 20, 2025
  • Response to ASX Aware LetterMay 21, 2025
  • Update on Scheme of Arrangement with CosetteJun 3, 2025
  • Mayne Pharma receives purported notice to terminate SIDJun 4, 2025
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer